Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

China flag China · Delayed Price · Currency is CNY
10.55
-0.43 (-3.92%)
May 21, 2026, 3:04 PM CST
Market Cap4.37B -14.2%
Revenue (ttm)288.53M +71.6%
Net Income32.53M
EPS0.09
Shares Out414.69M
PE Ratio123.56
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,780,702
Average Volume16,771,587
Open10.94
Previous Close10.98
Day's Range10.45 - 11.33
52-Week Range6.36 - 11.36
Beta0.37
RSI62.48
Earnings DateAug 26, 2026

About SHE:002693

Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Haikou, the People’s Republic of China. [Read more]

Sector Healthcare
Founded 2000
Employees 605
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002693
Full Company Profile

Financial Performance

Financial Statements